中药单体调控NF-κB信号通路干预卵巢癌研究进展
Research Progress on the Intervention of Traditional Chinese Medicine Monomers in Regulating the NF-κB Signaling Pathway for Ovarian Cancer
DOI: 10.12677/jcpm.2024.33135, PDF,   
作者: 张议中：黑龙江中医药大学研究生院，黑龙江 哈尔滨；韩凤娟：黑龙江中医药大学第一附属医院妇三科，黑龙江 哈尔滨
关键词: 中药单体；NF-κB信号通路；卵巢癌；研究进展；Chinese Medicine Monomer； NF-κB Signalling Pathway； Ovarian Cancer； Research Progress
摘要: 卵巢癌是女性三大恶性肿瘤之一，严重危害女性生命健康。卵巢癌发生发展过程中，众多信号通路发挥着至关重要的作用，其中NF-κB信号通路是主要调控通路之一。近年来，中医药抗肿瘤的优势逐渐显现，研究发现，人参皂苷Rg1、沙苑子苷A、黄芩苷和芍药内酯苷等多种中药单体可以通过调控NF-κB信号通路发挥抑制卵巢癌细胞增殖、迁移和侵袭，或诱导细胞凋亡。基于国内外研究现状，通过整理归纳中药单体通过调控NF-κB信号通路干预卵巢癌的研究进展，力求为中医药治疗卵巢癌提供参考，同时也为临床用药研发开拓思路。
Abstract: Ovarian cancer is one of the three major malignant tumours in women, which seriously endangers women’s life and health. During the development of ovarian cancer, many signalling pathways play a crucial role, among which NF-κB signalling pathway is one of the major regulatory pathways. In recent years, the anti-tumour advantages of traditional Chinese medicine have gradually emerged, and it has been found that a variety of traditional Chinese medicine monomers, such as ginsenoside Rg1, saxifrageoside A, baicalin and paeonolactone glycosides, can inhibit the proliferation, migration and invasion of ovarian cancer cells or induce apoptosis by regulating the NF-κB signalling pathway. Based on the current research situation at home and abroad, we are trying to provide reference for the treatment of ovarian cancer with traditional Chinese medicine and develop ideas for clinical drug development by summarising the research progress of the intervention of traditional Chinese medicine monomers in ovarian cancer through regulating the NF-κB signaling pathway.
文章引用：张议中, 韩凤娟. 中药单体调控NF-κB信号通路干预卵巢癌研究进展[J]. 临床个性化医学, 2024, 3(3): 944-950. https://doi.org/10.12677/jcpm.2024.33135

参考文献

[1] Webb, P.M. and Jordan, S.J. (2024) Global Epidemiology of Epithelial Ovarian Cancer. Nature Reviews Clinical Oncology, 21, 389-400. [Google Scholar] [CrossRef] [PubMed]
[2] Maleki, Z., Vali, M., Nikbakht, H., Hassanipour, S., Kouhi, A., Sedighi, S., et al. (2023) Survival Rate of Ovarian Cancer in Asian Countries: A Systematic Review and Meta-Analysis. BMC Cancer, 23, Article No. 558. [Google Scholar] [CrossRef] [PubMed]
[3] Fan, Z., Han, D., Fan, X. and Zhao, L. (2023) Ovarian Cancer Treatment and Natural Killer Cell-Based Immunotherapy. Frontiers in Immunology, 14, Article 1308143. [Google Scholar] [CrossRef] [PubMed]
[4] Zhang, X., Qiu, H., Li, C., Cai, P. and Qi, F. (2021) The Positive Role of Traditional Chinese Medicine as an Adjunctive Therapy for Cancer. BioScience Trends, 15, 283-298. [Google Scholar] [CrossRef] [PubMed]
[5] Wei, J., Liu, Z., He, J., Liu, Q., Lu, Y., He, S., et al. (2021) Traditional Chinese Medicine Reverses Cancer Multidrug Resistance and Its Mechanism. Clinical and Translational Oncology, 24, 471-482. [Google Scholar] [CrossRef] [PubMed]
[6] Yu, H., Lin, L., Zhang, Z., Zhang, H. and Hu, H. (2020) Targeting NF-κB Pathway for the Therapy of Diseases: Mechanism and Clinical Study. Signal Transduction and Targeted Therapy, 5, Article No. 209. [Google Scholar] [CrossRef] [PubMed]
[7] Li, Y., Wang, S., Li, P., Li, Y., Liu, Y., Fang, H., et al. (2021) Rad50 Promotes Ovarian Cancer Progression through NF-κB Activation. Journal of Cellular and Molecular Medicine, 25, 10961-10972. [Google Scholar] [CrossRef] [PubMed]
[8] 崔若凌, 管越, 辛彤, 等. 中医药调控相关信号通路在抑制卵巢癌中的作用机制[J]. 航空航天医学杂志, 2024, 35(3): 333-336.
[9] Sun, S. (2010) Non-canonical NF-κB Signaling Pathway. Cell Research, 21, 71-85. [Google Scholar] [CrossRef] [PubMed]
[10] O’Dea, E. and Hoffmann, A. (2009) NF-κB Signaling. WIREs Systems Biology and Medicine, 1, 107-115. [Google Scholar] [CrossRef] [PubMed]
[11] O’Dea, E. and Hoffmann, A. (2009) The Regulatory Logic of the NF-κB Signaling System. Cold Spring Harbor Perspectives in Biology, 2, a000216. [Google Scholar] [CrossRef] [PubMed]
[12] Devanaboyina, M., Kaur, J., Whiteley, E., Lin, L., Einloth, K., Morand, S., et al. (2022) NF-κB Signaling in Tumor Pathways Focusing on Breast and Ovarian Cancer. Oncology Reviews, 16, Article 10568. [Google Scholar] [CrossRef] [PubMed]
[13] Shuang, T., Wang, M., Zhou, Y. and Shi, C. (2016) Over-Expression of Nuclear NF-κB1 and C-Rel Correlates with Chemoresistance and Prognosis of Serous Epithelial Ovarian Cancer. Experimental and Molecular Pathology, 100, 139-144. [Google Scholar] [CrossRef] [PubMed]
[14] 李培培, 王红英, 温丽娜, 等. 关于NF-κB基因表达及相关信号通路在卵巢癌发生中作用的研究进展[J]. 中外女性健康研究, 2018(2): 24-25+33.
[15] Catley, M.C., Cambridge, L.M., Nasuhara, Y., Ito, K., Chivers, J.E., Beaton, A., et al. (2004) Inhibitors of Protein Kinase C (PKC) Prevent Activated Transcription. Journal of Biological Chemistry, 279, 18457-18466. [Google Scholar] [CrossRef] [PubMed]
[16] Mahanivong, C., Chen, H.M., Yee, S.W., Pan, Z.K., Dong, Z. and Huang, S. (2007) Protein Kinase Cα-Carma3 Signaling Axis Links Ras to NF-κB for Lysophosphatidic Acid-Induced Urokinase Plasminogen Activator Expression in Ovarian Cancer Cells. Oncogene, 27, 1273-1280. [Google Scholar] [CrossRef] [PubMed]
[17] Hu, Z., Cang, R., Zhang, H., Gao, Y., Zhang, X., Chen, X., et al. (2023) The Expression Levels of NF-κB and IKKβ in Epithelial Ovarian Cancer and Their Correlation with Drug Resistance-Related Genes MDR1, TOPOII, and ERCC1. Acta Biochimica Polonica, 70, 23-29. [Google Scholar] [CrossRef] [PubMed]
[18] Hufnagel, D.H., Wilson, A.J., Saxon, J., Blackwell, T.S., Watkins, J., Khabele, D., et al. (2020) Expression of P52, a Non-Canonical NF-kappaB Transcription Factor, Is Associated with Poor Ovarian Cancer Prognosis. Biomarker Research, 8, Article No. 45. [Google Scholar] [CrossRef] [PubMed]
[19] Hwang, J.W., Oh, J.H., Yoo, H., Lee, Y., Cho, C., Kwon, K., et al. (2012) Mountain Ginseng Extract Exhibits Anti-Lung Cancer Activity by Inhibiting the Nuclear Translocation of NF-κB. The American Journal of Chinese Medicine, 40, 187-202. [Google Scholar] [CrossRef] [PubMed]
[20] Chen, L., Sun, Z., Wang, F., Xu, C. and Geng, M. (2016) Protective Effects of Ginsenoside Rg1 against Hydrogen Peroxide-Induced Injury in Human Neuroblastoma Cells. Neural Regeneration Research, 11, 1159-1164. [Google Scholar] [CrossRef] [PubMed]
[21] Li, L., Wang, Y., Qi, B., Yuan, D., Dong, S., Guo, D., et al. (2014) Suppression of PMA-Induced Tumor Cell Invasion and Migration by Ginsenoside Rg1 via the Inhibition of NF-κB-Dependent MMP-9 Expression. Oncology Reports, 32, 1779-1786. [Google Scholar] [CrossRef] [PubMed]
[22] 刘丹, 刘婷, 赵乐, 等. 人参皂苷Rg1通过NF-κB阻断缺氧诱导卵巢癌SKOV3细胞EMT[J]. 中国妇幼健康研究, 2017, 28(3): 273-275+278.
[23] 于现阔, 许梦莹, 罗寒燕, 等. 炮制对沙苑子中黄酮类成分含量的影响[J]. 中华中医药杂志, 2020, 35(3): 1508-1511.
[24] 白勇, 孙安盛, 吴芹. 沙苑子总黄酮和百草酸的体内外抗肿瘤作用[J]. 中成药, 2014, 36(4): 684-689.
[25] 于猛, 热增才旦, 杨科, 等. 沙苑子苷A通过抑制血管生成抗肿瘤作用研究[J]. 药物评价研究, 2020, 43(1): 21-26.
[26] 宋慧, 贾文娟. 沙苑子苷A下调NF-кB信号通路抑制卵巢癌细胞恶性表型的研究[J]. 中国性科学, 2023, 32(12): 81-86.
[27] Liang, S., Deng, X., Lei, L., Zheng, Y., Ai, J., Chen, L., et al. (2019) The Comparative Study of the Therapeutic Effects and Mechanism of Baicalin, Baicalein, and Their Combination on Ulcerative Colitis Rat. Frontiers in Pharmacology, 10, Article 1466. [Google Scholar] [CrossRef] [PubMed]
[28] 彭虹瑶. 黄芩苷通过调控NF-κB信号通路抑制卵巢癌的机制研究[D]: [硕士学位论文]. 成都: 成都中医药大学, 2023.
[29] 吴丽, 王丽丽, 费文婷, 等. 芍药苷和芍药内酯苷对小鼠疼痛模型的镇痛作用及对β-EP、PGE_2的影响[J]. 中华中医药杂志, 2018, 33(3): 915-918.
[30] 韩立, 史芳瑜, 郭晓娟, 等. 芍药内酯苷调控NF-κB抑制卵巢癌转移的作用研究[J]. 中国医院药学杂志, 2022, 42(22): 2361-2365.
[31] 张立国, 胡甜甜, 张芳芳, 等. 丹参和紫丹参脂溶性成分的UPLC及LC-MS/MS分析[J]. 中国中药杂志, 2019, 44(6): 1208-1215.
[32] 彭翔云, 王鹤, 王岚, 等. 二氢丹参酮Ⅰ通过核因子κB信号通路抑制卵巢癌进展的研究[J]. 中国医院用药评价与分析, 2020, 20(6): 656-659.
[33] Miyazawa, M. and Hisama, M. (2003) Antimutagenic Activity of Flavonoids from Chrysanthemum morifolium. Bioscience, Biotechnology, and Biochemistry, 67, 2091-2099. [Google Scholar] [CrossRef] [PubMed]
[34] Kraft, C., Jenett-Siems, K., Siems, K., Jakupovic, J., Mavi, S., Bienzle, U., et al. (2003) In Vitro Antiplasmodial Evaluation of Medicinal Plants from Zimbabwe. Phytotherapy Research, 17, 123-128. [Google Scholar] [CrossRef] [PubMed]
[35] 周玉芝, 洛若愚, 邢辉. 刺槐素通过下调NF-κB/COX-2表达抑制卵巢癌细胞SKOV3增殖[J]. 辽宁中医药大学学报, 2016, 18(7): 50-53.
[36] Zhang, Y.S., Ning, Z.X., Yang, S.Z. and Wu, H. (2003) Antioxidation Properties and Mechanism of Action of Dihydromyricetin from Ampelopsis grossedentata. Acta Pharmaceutica Sinica, 38, 241-244.
[37] Robyt, J.F., Yoon, S. and Mukerjea, R. (2008) Dextransucrase and the Mechanism for Dextran Biosynthesis. Carbohydrate Research, 343, 3039-3048. [Google Scholar] [CrossRef] [PubMed]
[38] 刘天凤. 白蔹素对卵巢癌迁移和侵袭的影响及其机制的实验研究[D]: [博士学位论文]. 济南: 山东大学, 2015.
[39] Jiao, Y., Wu, Y. and Du, D. (2018) Polydatin Inhibits Cell Proliferation, Invasion and Migration, and Induces Cell Apoptosis in Hepatocellular Carcinoma. Brazilian Journal of Medical and Biological Research, 51, e6867. [Google Scholar] [CrossRef] [PubMed]
[40] 曾博洁, 许剑利 ,董珊. 虎杖多糖通过NF-κB/P65信号通路抑制卵巢癌细胞增殖[J]. 宁夏医科大学学报, 2022, 44(2): 109-113+121.